Brian K Halak
CIK 1354718 · last filed 2023-01-06
Brian K Halak is a corporate insider who has filed 81 SEC Form 4 insider transactions across 18 companies since 2007. The most recent filing, for ALIM, was dated Jan 6, 2023. Across all open-market trades the lifetime net is +$78.9M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $334.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$334.54M
18
81
$78.95M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALIMERA SCIENCES INC (ALIM) Delisted | Director | 327 | $5.54 | $1.8K | $0 | 15 | 2023-01-06 |
| Dicerna Pharmaceuticals Inc (DRNA) Delisted | Director | 45,665 | $38.22 | $1.75M | -$19.89M | 10 | 2018-11-06 |
| Evoke Pharma Inc (OMED) Delisted | 10%+ Owner | 959,256 | — | — | -$4.77M | 8 | 2016-04-27 |
| Tobira Therapeutics, Inc. (TBRA) Delisted | 10%+ Owner | 3,553,322 | — | — | $20.65M | 1 | 2015-05-06 |
| Durata Therapeutics, Inc. (DRTX) Delisted | 10%+ Owner | 16,529 | — | — | $7.06M | 2 | 2014-11-18 |
| ATRA | 10%+ Owner | 15,890 | $10.41 | $165.4K | $141.8K | 1 | 2014-10-21 |
| VCYT | 10%+ Owner | 5,826,588 | $47.33 | $275.77M | $0 | 2 | 2014-09-12 |
| Achaogen, Inc. (AKAO) Delisted | 10%+ Owner | 1,987,049 | — | — | $0 | 1 | 2014-03-17 |
| CADENCE PHARMACEUTICALS INC (CADX) Delisted | 10%+ Owner | 97,377 | — | — | $17.01M | 10 | 2014-02-14 |
| TNDM | 10%+ Owner | 3,189,058 | $16.60 | $52.94M | $0 | 2 | 2013-11-19 |
| Ocera Therapeutics, Inc. (TZYM) Delisted | 10%+ Owner | 15,731 | — | — | $8.00M | 1 | 2013-07-16 |
| ESPR | 10%+ Owner | 1,786,012 | $3.15 | $5.63M | $4.00M | 1 | 2013-07-02 |
| ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | 10%+ Owner | 159,896 | — | — | $0 | 3 | 2013-01-18 |
| Orexigen Therapeutics, Inc. (OREX) Delisted | 10%+ Owner | 2,967,415 | — | — | $18.29M | 12 | 2011-12-22 |
| Clovis Oncology, Inc. (CLVS) Delisted | 10%+ Owner | 13,958 | $0.08 | $1.1K | $12.11M | 1 | 2011-11-21 |
| ZOGENIX, INC. (ZGNX) Delisted | 10%+ Owner | 169,251 | $26.68 | $4.52M | $16.40M | 2 | 2011-09-20 |
| VNDA | Director | 7,276 | $5.87 | $42.7K | $0 | 4 | 2010-03-30 |
| Volcano Corp (VOLC) Delisted | 10%+ Owner | 60,133 | — | — | -$53.3K | 3 | 2008-06-09 |
Recent Filings
81 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-01-06 | ALIMERA SCIENCES INC (ALIM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-11-04 | ALIMERA SCIENCES INC (ALIM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-09-17 | ALIMERA SCIENCES INC (ALIM) Delisted | Other (J) | +215 | $0 | EDGAR |
| 2020-06-22 | ALIMERA SCIENCES INC (ALIM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-21 | ALIMERA SCIENCES INC (ALIM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-11-06 | Dicerna Pharmaceuticals Inc (DRNA) Delisted | Sell (S) | −335,000 | -$4.46M | EDGAR |
| 2018-11-05 | Dicerna Pharmaceuticals Inc (DRNA) Delisted | Sell (S) | −565,000 | -$7.72M | EDGAR |
| 2018-11-01 | Dicerna Pharmaceuticals Inc (DRNA) Delisted | Sell (S) | −564,300 | -$7.71M | EDGAR |
| 2018-06-25 | Dicerna Pharmaceuticals Inc (DRNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-06-21 | ALIMERA SCIENCES INC (ALIM) Delisted | Grant (A) | — | $0 | EDGAR |